| 000 | 04647cam a2200349 a 4500 | ||
|---|---|---|---|
| 999 |
_c10008 _d10008 |
||
| 001 | 15311946 | ||
| 003 | OSt | ||
| 005 | 20180725143713.0 | ||
| 008 | 080602s2008 dcua b 001 0 eng | ||
| 010 | _a 2008022042 | ||
| 020 | _a9780973467666 (softcover) | ||
| 040 |
_aDLC _cDLC _dDLC |
||
| 050 | 0 | 0 |
_aHD9999.B442 _bF75 2008 |
| 082 | 0 | 0 |
_a660.6068 _222 _bF.Y.B |
| 100 | 1 | _aFriedman, Yali. | |
| 245 | 1 | 0 |
_aBuilding biotechnology : _bbusiness, regulations, patents, law, politics, science / _cYali Friedman. |
| 250 | _a3rd ed. | ||
| 260 |
_aWashington, DC : _bLogos Press, _cc2008. |
||
| 264 |
_aWashington, DC : _bLogos Press, _cc2008. |
||
| 300 |
_axvi, 433 p. : _bill. ; _c24 cm. |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 504 | _aIncludes bibliographical references (p.399-404) and index. | ||
| 505 | _aIntroduction -- The Development of Biotechnology -- Knowledge and Skills -- Application -- Commercialization -- Industry Trends -- Science -- Introduction to Molecular Biology -- Information Flow in Molecular Biology -- The Big Picture -- Drug Development --Biologicvs.Pharmaceutical Drug Development -- The Five Basic Steps of Drug Development -- Qualities of a ¿Good¿ Drug -- Tools and Techniques -- Bioinformatics -- Combinatorial Chemistry -- Drug Delivery -- Functional Genomics -- Manufacturing -- Microarrays -- Proteomics -- Nanotechnology -- Applications -- Green Biotechnology: Agriculture --White Biotechnology: Industrial Processes and Bio-based Products --Red Biotechnology: Medical Applications --Laws, Regulations, and PoliticsIntellectual Property -- Patents -- When Patents Expire -- Patent Infringement, Exemptions, and Licenses -- Trade Secrets --- Trademark -- Copyright . -- The Role of Intellectual Property in Biotechnology --- Regulation -- Food and Drug Administration -- Department of Agriculture -- Environmental Protection Agency --- Securities and Exchange Commission -- Politics -- Balancing Innovation Incentives with Economic Constraints --The Business of Biotechnology -- Biotechnology Company Fundamentals -- Company Formation --Business Model -- Team -- Company Characteristics -- Finance -- Development Stages and Funding -- Private Equity -- Public Markets -- Other Funding Sources -- Valuation -- Research and Development -- R&D Stages -- Project Selection -- Outsourcing Innovation -- Marketing -- Marketing as a Guide for R&D -- Market Structure and Marketing Environment -- Reimbursement -- Marketing Planning and Strategy -- Licensing, Alliances, and Mergers -- Licensing and Outsourcing -- Alliance Partnerships -- Mergers and Acquisitions -- Selecting Partnership Options -- Managing Biotechnology -- Starting Up -- Managing R&D -- Intellectual Property Protection -- Management Changes with Growth -- Dealing with Failure -- Public Relations -- International Biotechnology -- Benchmarking against the United States -- Intellectual Property Protection -- Regulation -- Operations -- Finance -- Conclusion -- Building Biotechnology -- Business Models -- First Steps -- Selecting Opportunities and Business Planning -- Investing -- Caveat Emptor -- Investing in Biotechnology -- Strategy -- Conclusion -- Career Development -- Job Descriptions -- Ph.D., MBA, or Both? -- Final Words -- Appendices -- Internet Resources -- News and Information -- Investing and Competitive Intelligence -- Angel Funding -- Federal Funding -- Industry Organizations -- Annotated Bibliography -- Science -- Intellectual Property and Regulation -- Business -- Glossary -- Science -- Legal -- Regulatory -- Business -- Index | ||
| 520 | _aThe definitive biotechnology industry primer, now in its 3rd edition. Building Biotechnology provides a comprehensive fundamentals-based overview of the commercialization of biotechnology. Expanding on this foundation to ensure a practical appreciation of operational issues in the biotechnology industry, Building Biotechnology adds real-world examples on topics such as the hidden pitfalls of common operational decisions; practical considerations in selecting business models and funding options; strategies to overcome developmental failures; and, methods to leverage options to strengthen development plans. | ||
| 650 | 0 | _aBiotechnology industries. | |
| 856 | 4 | 1 |
_3Table of contents only _uhttp://www.loc.gov/catdir/toc/ecip0819/2008022042.html |
| 906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
| 942 |
_2ddc _cBK |
||